Roka Bioscience, Inc. to present at The MicroCap Conference on October 24-25 in Philadelphia

ARLINGTON, VA / ACCESSWIRE / October 11, 2016 / Roka Bioscience, Inc. ROKA will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with 60 other companies in the microcap universe.

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.

This event is free for private and institutional investors - to learn more, please click here.

About Roka Bioscience, Inc.

Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory authorities. The company was founded in 2009 and is headquartered in Warren, New Jersey.

SOURCE: Roka Bioscience